Abstract
Objectives:
Examine treatment outcomes and define factors that influence survival in patients underwent primary surgery with postoperative radiotherapy for pN2 head and neck carcinoma.
Methods:
Two hundred nine patients underwent primary surgery with postoperative radiotherapy between 1994 and 2011. Primary tumor sites were 70 oropharynx, 48 hypopharynx, 47 larynx, 41 oral cavity, and 3 sinonasal cavity. There were 21, 83, 60 and 45 patients with stage T1 to T4 cancers, respectively. The N stages were 20 N2a, 129 N2b, and 60 N2c.
Results:
The recurrence rate was 40% (83/209) over a mean observation period of 39 months. The 5-year disease free survival (DFS), disease specific survival (DSS), and overall survival (OS) rate in our cohort was 44%, 60%, and 56%, respectively. Patients with advanced T stage or extracapsular spread had a significant adverse effect on 5-year DFS, DSS, OS rate according to the Kaplan-Meier survival curves. Multivariate Cox regression analysis confirmed the significant association between 5-year DSS rate and advanced T stage (hazard ratio (HR), 2.20; 95% confidence interval (CI), 1.26-3.82; P = 0.005) and extracapsular spread (HR, 2.29; 95% CI, 1.24-4.21; P = 0.008).
Conclusions:
Factors that affected prognosis were T stage and extracapsular spread in patients who underwent primary surgery with postoperative radiotherapy for pN2 head and neck carcinoma. An aggressive therapeutic approach may be suitable for these patients.
Get full access to this article
View all access options for this article.